Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections: An Emerging Pathogen?

Jonatan David Nunez Breton; Gabriel Hernandez; Jacques Simkins; Sandra Viviana Chaparro

doi:10.1111/tid.12957

Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections: An Emerging Pathogen?

Jonatan David Nunez Breton
, Gabriel Hernandez
, Jacques Simkins
, Sandra Viviana Chaparro

Research output: Contribution to journal › Article › peer-review

Abstract

The use of left ventricular assist device is associated with improvement in survival in patients with refractory heart failure. However, driveline infection limits the success of its use as it is associated with significant mortality. We describe the first 2 cases of Mycobacterium abscessus driveline infection. Both patients had persistent infection despite of aggressive antibiotic treatment and local debridement, and only improved after removal of their left ventricular assist devices.

Original language	English
Pages (from-to)	e12957
Journal	Transplant Infectious Disease
Volume	20
Issue number	5
DOIs	https://doi.org/10.1111/tid.12957
State	Published - Oct 2018
Externally published	Yes

Keywords

Anti-Bacterial Agents/therapeutic use
Debridement
Heart Failure/surgery
Heart-Assist Devices/adverse effects
Humans
Male
Middle Aged
Mycobacterium abscessus/isolation & purification
Prosthesis-Related Infections/microbiology
Treatment Outcome

Access to Document

10.1111/tid.12957

Cite this

@article{227e42433ee940c9bb4571d1bc9887c9,

title = "Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections: An Emerging Pathogen?",

abstract = "The use of left ventricular assist device is associated with improvement in survival in patients with refractory heart failure. However, driveline infection limits the success of its use as it is associated with significant mortality. We describe the first 2 cases of Mycobacterium abscessus driveline infection. Both patients had persistent infection despite of aggressive antibiotic treatment and local debridement, and only improved after removal of their left ventricular assist devices.",

keywords = "Anti-Bacterial Agents/therapeutic use, Debridement, Heart Failure/surgery, Heart-Assist Devices/adverse effects, Humans, Male, Middle Aged, Mycobacterium abscessus/isolation \& purification, Prosthesis-Related Infections/microbiology, Treatment Outcome",

author = "\{Nunez Breton\}, \{Jonatan David\} and Gabriel Hernandez and Jacques Simkins and Chaparro, \{Sandra Viviana\}",

note = "{\textcopyright} 2018 John Wiley \& Sons A/S. Published by John Wiley \& Sons Ltd.",

year = "2018",

month = oct,

doi = "10.1111/tid.12957",

language = "English",

volume = "20",

pages = "e12957",

journal = "Transplant Infectious Disease",

issn = "1398-2273",

number = "5",

}

TY - JOUR

T1 - Mycobacterium abscessus Left Ventricle Assist Device Driveline Infections

T2 - An Emerging Pathogen?

AU - Nunez Breton, Jonatan David

AU - Hernandez, Gabriel

AU - Simkins, Jacques

AU - Chaparro, Sandra Viviana

PY - 2018/10

Y1 - 2018/10

N2 - The use of left ventricular assist device is associated with improvement in survival in patients with refractory heart failure. However, driveline infection limits the success of its use as it is associated with significant mortality. We describe the first 2 cases of Mycobacterium abscessus driveline infection. Both patients had persistent infection despite of aggressive antibiotic treatment and local debridement, and only improved after removal of their left ventricular assist devices.

AB - The use of left ventricular assist device is associated with improvement in survival in patients with refractory heart failure. However, driveline infection limits the success of its use as it is associated with significant mortality. We describe the first 2 cases of Mycobacterium abscessus driveline infection. Both patients had persistent infection despite of aggressive antibiotic treatment and local debridement, and only improved after removal of their left ventricular assist devices.

KW - Anti-Bacterial Agents/therapeutic use

KW - Debridement

KW - Heart Failure/surgery

KW - Heart-Assist Devices/adverse effects

KW - Humans

KW - Male

KW - Middle Aged

KW - Mycobacterium abscessus/isolation & purification

KW - Prosthesis-Related Infections/microbiology

KW - Treatment Outcome

U2 - 10.1111/tid.12957

DO - 10.1111/tid.12957

M3 - Article

C2 - 29896814

SN - 1398-2273

VL - 20

SP - e12957

JO - Transplant Infectious Disease

JF - Transplant Infectious Disease

IS - 5

ER -